The HPV test is significantly more sensitive than cytology for the detection of cervical abnormalities caused by HPV infection, and a single HPV test for which oncogenic HPV is not detected is considered sufficient to safely discharge women from the NCSPNational Cervical Screening ProgramA joint program of the Australian, state and territory governments. It aims to reduce morbidity and mortality from cervical cancer, in a cost-effective manner through an organised approach to cervical screening. The program encourages women in the target population to have regular Pap smears..MSACThe Australian Medical Services Advisory Committee has recommended that women between the ages of 70 and 74 years can cease 5 yearly screening after a HPV test at which oncogenic HPV is not detected.
|MSACThe Australian Medical Services Advisory Committee evidence-based recommendation|
REC6.16: Women aged 70–74 years in whom oncogenic HPV is not detected (exit testing)
REC6.17: Referral of women aged 70–74 years with a positive oncogenic HPV test result (exit testing)
- Medical Services Advisory Committee. MSAC Outcomes. Application No. 1276 – Renewal of the National Cervical Screening Program. [homepage on the internet] Canberra: Australian Government Department of Health; 2014 [updated 2015 Apr]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/FD36D6990FFAA639CA25799200058940/$File/1276%20-%20Final%20MSAC%20PSD%20-%20NCSP%20Renewal.pdf.